NewLink Genetics Corp (NASDAQ:NLNK)

7.01
Delayed Data
As of Feb 21
 -0.12 / -1.68%
Today’s Change
5.90
Today|||52-Week Range
25.17
-13.56%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close7.13
Today’s open7.17
Day’s range6.99 - 7.38
Volume657,119
Average volume (3 months)942,160
Market cap$259.9M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+9.98%
Earnings growth (next 5 years)+17.26%
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
OBSVObseva SA+0.72+5.11%
ATHXAthersys Inc+0.01+0.72%
NYMXNymox Pharmaceutical...-0.06-1.88%
KURAKura Oncology Inc+0.30+1.35%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts